Table 1. Patient demographics and baseline clinical features.
| Characteristic | Total frequency (%) |
|---|---|
| Age at diagnosis (yrs) | |
| 40 or less | 11 (21%) |
| 41 – 60 | 24 (45%) |
| 61 or greater | 18 (34%) |
| Gender | |
| Female | 33 (62%) |
| Male | 20 (38%) |
| Geographic Origin | |
| Caribbean/Hispanic | 48 (91%) |
| African | 5 (9%) |
| ATLL Subtype | |
| Acute | 36 (68%) |
| Lymphomatous | 14 (26%) |
| Chronic | 3 (6%) |
| Smoldering | 0 (0.0%) |
| Symptoms and pathological features | |
| Lymphadenopathy | 41 (77%) |
| Rash | 16 (30%) |
| Pleural Effusion | 21 (40%) |
| Ascites | 11 (21%) |
| Bone Marrow Involvement (40)a | 31 (78%) |
| Bone Lesions (51)a | 7 (14%) |
| CNS Involvement (27)a | 9 (33%) |
| Hypercalcemia | 31 (59%) |
| Lymphocytosis | 27 (51%) |
| Abnormal cytogenetics (22)a | 13 (59%) |
| Immunophenotype | |
| Typical (CD4+/CD8-) | 44 (83%) |
| Atypical (CD4+/CD8+ or CD4-/CD8-) | 9 (17%) |
a
Total number of patients tested for this variable in parentheses.
(n=53).